K36 Therapeutics
Cambridge, MA
K36 Therapeutics mission to translate epigenetic modulation of oncogenic pathways into first-in-class small molecule therapies.
k36tx.comCompany Details
Founded
- 2021
Employees
- Between 5 - 20 employees
Raised
- $100,000,000
Headquarters Location
- Cambridge, MA
Public
- No
Acquired
- No
CEO
Terrence Connolly
Company Collections
These are collections K36 Therapeutics is a part of. Click on the collection name to view similar companies.